Durvalumab Plus FLOT Ups Survival in Early Upper-GI Cancer

, 2025-10-18 16:41:00
Overall survival outcomes in MATTERHORN trial support perioperative durvalumab plus chemotherapy as standard of care.
Medscape Medical News
Source link